• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    Vitality Biopharma Advisor Will Present Pediatric IBD Case Study

    Bryan Mc Govern
    Jun. 21, 2017 08:42AM PST
    Cannabis Investing News

    Vitality Biopharma announced company advisor Dr. Natasha Ryz will be presenting at an international research symposium in Montréal.

    Vitality Biopharma (OTCQB:VBIO) announced company advisor Dr. Natasha Ryz will be presenting at an international research symposium in Montréal.
    As quoted in the press release:

    Dr. Ryz will provide a poster presentation titled “Cannabinoid Treatment Induces Remission in Drug-Resistant Pediatric Inflammatory Bowel Disease: A Case Report.” The case report provides clinical results describing a 13-year old boy with drug-resistant Crohn’s disease that achieved disease remission after cannabinoid treatment. Dr. Ryz holds a Ph.D. in Experimental Medicine from the University of British Columbia, where she was a Vanier Scholar.

    Click here to read the full press release.

    Source: www.marketwired.com

    british columbiacannabis investinginflammatory bowel diseasevitality biopharmaclinical results
    The Conversation (0)

    Go Deeper

    AI Powered

    Botanix Pharmaceuticals

    Biomerica Receives Notice of Allowance for Irritable Bowel Syndrome (IBS) Test Panel and Methods in Korea

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    extractX

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×